Black Rock Inc. Stoke Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,409,169 shares of STOK stock, worth $187 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,409,169
Previous 3,858,463
40.19%
Holding current value
$187 Million
Previous $52.1 Million
40.29%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding STOK
# of Institutions
139Shares Held
58MCall Options Held
2.7KPut Options Held
57.4K-
Lynx1 Capital Management LP San Juan, PR5.4MShares$187 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$178 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$161 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$152 Million6.04% of portfolio
-
Morgan Stanley New York, NY3.57MShares$124 Million0.0% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.37B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...